The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes

Lancet

Volumn 366, Issue 9502, 2005, Pages 2058-2061

  Jeffcoate, William J ^a   Game, Fran ^a   Cavanagh, Peter R ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ETANERCEPT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 1BETA; OSTEOCLAST DIFFERENTIATION FACTOR;

BLOOD VESSEL CALCIFICATION; CLINICAL PRACTICE; CYTOKINE PRODUCTION; DIABETIC FOOT; DIABETIC NEUROPATHY; HUMAN; INFECTION RISK; INFLAMMATORY INFILTRATE; JOINT INJURY; NEUROPATHIC JOINT DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 28844483877     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67029-8     Document Type: Note

References (34)

1. J-M Charcot Sur quelques arthropathies qui paraissent dépendre d'une lésion du cerveau ou de la moëlle épinière Arch Physiol Norm Pathol 1 1868 161 178
2. JK Mitchell On a new practice in acute and chronic rheumatism Am J Med Sci 8 1831 55 64
3. WR Jordan Neuritic manifestations in diabetes mellitus Arch Intern Med 57 1936 307 358
4. W Jeffcoate, J Lima, L Nóbrega The Charcot foot Diabet Med 17 2000 253 258
5. SM Rajbhandari, RC Jenkins, C Davies, S Tesfaye Charcot neuroarthropathy in diabetes mellitus Diabetologia 45 2002 1085 1096
6. PL Selby, MJ Young, AJM Boulton Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 11 1994 28 31
7. S Weir Mitchell On a rare vaso-motive neurosis of the extremities and on the abnormalities with which it may be confounded Am J Med Sci 76 1878 17 36
8. MR Leriche Sur quelques maladies osseuses et articulaires d'origine vaso-motrice et sur leur traitement Seance 1927 1022 1031 6 Juillet
9. M Rix, H Andreasson, P Eskildsen Impact of peripheral neuropathy on bone density in patients with type 1 diabetes Diabetes Care 22 1999 827 831
10. NL Petrova, AVM Foster, ME Edmonds Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes Diabet Med 22 2005 756 761
11. LC Hofbauer, AE Heufelder The roles of receptor activator of nuclear factor-κB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases J Clin Endocrinol Metab 85 2000 2355 2363
12. WJ Boyle, WS Simonet, DL Lacey Osteoclast differentiation and activation Nature 423 2003 337 342
13. LC Hofbauer, M Schoppet Clinical implications of the osteoprotegerin/ RANKL/RANK system for bone and vascular diseases JAMA 292 2004 490 495
14. L Demer, M Abedin Skeleton key to vascular disease J Am Coll Cardiol 44 2004 1977 1979
15. S Sinha, C Munichoodappa, GP Kozak Neuro-arthropathy (Charcot joints) in diabetes mellitus: a clinical study of 101 cases Medicine (Baltimore) 51 1972 191 210
16. MZ Jiang, H Tsukahara, Y Ohshima Effects of antioxidants and nitric oxide on TNF-alpha-induced adhesion molecule expression and NF-kappaB activation in human dermal microvascular endothelial cells Life Sci 75 2004 1159 1170
17. Y Tintut, S Morony, LL Demer Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo Arterioscler Thromb Vasc Biol 24 2004 e6 e10
18. KK Yerneni, W Bai, BV Khan, RM Medford, R Natarajan Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells Diabetes 48 1999 855 864
19. A Bierhaus, S Schiekofer, M Schwaninger Diabetes-associated sustained activation of the transcription nuclear factor-kappaB Diabetes 50 2001 2792 2808
20. A Aljada, H Ghanim, R Saadeh, P Dandona Insulin inhibits NFkappaB and MCP-1 expression in human endothelial cells J Clin Endocrinol Metab 86 2001 450 453
21. W Jeffcoate Vascular calcification and osteolysis in diabetic neuropathy: is RANK-L the missing link? Diabetologia 47 2004 1488 1492
22. SA Herbst, KB Jones, CL Saltzman Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density J Bone Joint Surg Br 86 2004 378 383
23. WJ Jeffcoate, BA Lipsky Controversies in diagnosing and managing osteomyelitis of the foot in diabetes Clin Infect Dis 39 suppl 2 2004 S115 S122
24. SV Edelman, EM Kosofsky, RA Paul, GP Kozak Neuro-arthropathy (Charcot's joints) in diabetes mellitus following revascularisation surgery Acrh Int Med 147 1987 1504 1508
25. JE Fleischli, RB Anderson, WH Davis Dorsiflexion metatarsal osteotomy for treatment of recalcitrant diabetic neuropathic ulcers Foot Ankle Int 20 1999 80 85
26. T Fujita, H Shiba, TE Van Dyke, H Kurihara Differential effects of growth factors and cytokines on the synthesis of SPARC, DNA, fibronectin and alkaline phosphatase activity in humam periodontal cells Cell Biol Int 28 2004 281 286
27. T Kon, TJ Cho, T Aizawa Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing J Bone Miner Res 16 2001 1004 1014
28. LC Gerstenfeld, TJ Cho, T Kon Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signalling Cells Tissues Organs 169 2001 285 294
29. N Saidenberg-Kermanac'h, N Bessis, M Cohen-Salal, MC De Vernejout, M-C Boissier Osteoprotegerin and inflammation Eur Cytokine Netw 13 2002 144 153
30. J Lam, Y Abu-Amer, CA Nelson, DH Fremont, FP Ross, SL Teitelbaum Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis Ann Rheum Dis 61 suppl 2 2002 ii82 ii83
31. J Sugawara, K Hayashi, F Kaneko, H Yamada, T Kizuka, H Tanaka Reductions in basal limb blood flow and lumen diameter after short-term leg casting Med Sci Sports Exerc 36 2004 1689 1694
32. M Yamaguchi, T Kojima, M Kanekawa, N Aihara, A Nogimura, K Kasai Neuropeptides stimulate production of interleukin-1beta, interleukin-6, and tumor necrosis factor-α in human dental pulp cells Inflamm Res 53 2004 199 204
33. SA Shapiro, KB Stansberry, MA Hill Normal blood flow response and vasomotion in the diabetic Charcot foot J Diabetes Complications 12 1998 147 153
34. P Celec Nuclear factor kappa B: molecular biomedicine - the next generation Biomed Pharmacother 58 2004 365 371